Items where Author is "Ghajarzadeh, M."

Article

(2022) Autoimmune hemolytic anemia after treatment with fingolimod in a patient with multiple sclerosis (MS): A case report and review of the literature. Autoimmunity Reviews. p. 2. ISSN 1568-9972

(2022) COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis. NEUROLOGICAL SCIENCES. pp. 4085-4094. ISSN 1590-1874 1590-3478 J9 - NEUROL SCI

(2022) Incidence of cancer in patients with multiple sclerosis (MS) who were treated with fingolimod: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Parkinson's disease and COVID-19: a systematic review and meta-analysis. Neurol Sci. pp. 775-783. ISSN 1590-1874 (Print) 1590-1874

(2022) Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. p. 103392. ISSN 2211-0356 (Electronic) 2211-0348 (Linking)

(2022) Percutaneous posterior tibial nerve stimulation (PTNS) for lower urinary tract symptoms (LUTSs) treatment in patients with multiple sclerosis (MS): A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2022) Predictors of Catching COVID-19 Infection during Pandemic Stage in Patients with Multiple Sclerosis (MS). International Journal of Preventive Medicine. p. 102. ISSN 2008-7802 (Print) 2008-8213 (Electronic) 2008-7802 (Linking)

(2022) Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis. Neurol Sci. pp. 233-241. ISSN 1590-1874

(2022) Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ) Questionnaire. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE. ISSN 2008-7802 2008-8213 J9 - INT J PREVENTIVE MED

(2022) Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder. Current Journal of Neurology. pp. 206-210. ISSN 2717-011X

(2022) The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis. Neurologia (Engl Ed). ISSN 2173-5808

(2022) The prevalence of restless legs syndrome (RLS) in patients with multiple sclerosis (MS): a systematic review and meta-analysis-an update. Neurol Sci. ISSN 1590-1874

(2022) The prevalence of sexual dysfunction (SD) and erectile dysfunction (ED) in men with multiple sclerosis (MS): a systematic review and meta-analysis. Neurologia (Engl Ed). ISSN 2173-5808

(2021) Deep brain stimulation for multiple sclerosis tremor: A systematic review and meta-analysis. MULTIPLE SCLEROSIS AND RELATED DISORDERS. ISSN 2211-0348 2211-0356 J9 - MULT SCLER RELAT DIS

(2021) Efficacy and safety of rituximab in treating patients with Neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis. Autoimmunity Reviews. ISSN 1568-9972

(2021) Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurological Sciences. pp. 2615-2618. ISSN 1590-1874

(2021) Prevalence of seizure/epilepsy in patients with multiple sclerosis: A systematic review and meta-analysis. International Journal of Preventive Medicine. ISSN 2008-7802

(2021) The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis. Neurol Sci. pp. 1-7. ISSN 1590-1874 (Print) 1590-1874

(2021) The prevalence of cognitive impairment in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2020) Characteristics of COVID-19 disease in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2020) Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire. Journal of Multidisciplinary Healthcare. pp. 609-613. ISSN 1178-2390

(2020) Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Multiple Sclerosis and Related Disorders. ISSN 2211-0348

(2020) Screening neuromyelitis optica patients for COVID-19 infection. Autoimmunity Reviews. ISSN 1568-9972

(2020) The prevalence of migraine in multiple sclerosis (MS): A systematic review and meta-analysis. Journal of Clinical Neuroscience. pp. 33-38. ISSN 0967-5868